The invention relates to a use of serum fraction of platelet rich fibrin (SPRF) for increasing mesenchymal stem cell (MSC) proliferation rate wherein said differentiated MSCs maintain their potential to differentiate in several cell types. The invention also relates to SPRF for use in therapy, wherein in said therapy SPRF obtained from a donor subject used to increase proliferation rate of the patients MSCs.
